The Food and Drug Administration (FDA, Agency, or we) is extending the proposal period for the ``Quality Metrics Site Visit Program for Center for Drug Evaluation and Research and Center for Biologics Evaluation and Research Staff,'' published in the Federal Register of June 29, 2018. FDA is extending the proposal period to allow interested persons additional time to submit an electronic or written proposal.
Document
Quality Metrics Site Visit Program for Center for Drug Evaluation and Research and Center for Biologics Evaluation and Research Staff; Information Available to Industry; Extension of the Proposal Period
The Food and Drug Administration (FDA, Agency, or we) is extending the proposal period for the ``Quality Metrics Site Visit Program for Center for Drug Evaluation and Research a...
Legal Citation
Federal Register Citation
Use this for formal legal and research references to the published document.
83 FR 41080
Web Citation
Suggested Web Citation
Use this when citing the archival web version of the document.
“Quality Metrics Site Visit Program for Center for Drug Evaluation and Research and Center for Biologics Evaluation and Research Staff; Information Available to Industry; Extension of the Proposal Period,” thefederalregister.org (August 17, 2018), https://thefederalregister.org/documents/2018-17783/quality-metrics-site-visit-program-for-center-for-drug-evaluation-and-research-and-center-for-biologics-evaluation-and-r.